Showing results (71-80 of 121) with videos related to

Sort By:
Pageof 13
Bioorganic & Medicinal Chemistry|October 11, 2005
Exploration of acyl sulfonamides as carboxylic acid replacements in protease inhibitors of the hepatitis C virus full-length NS3Robert Rönn, Yogesh A Sabnis, Thomas Gossas, et al.
Journal of Medicinal Chemistry|December 3, 2002
Relationships between structure and interaction kinetics for HIV-1 protease inhibitorsPer-Olof Markgren, Wesley Schaal, Markku Hämäläinen, et al.
Bioorganic & Medicinal Chemistry|April 24, 2007
Evaluation of a diverse set of potential P1 carboxylic acid bioisosteres in hepatitis C virus NS3 protease inhibitorsRobert Rönn, Thomas Gossas, Yogesh A Sabnis, et al.
Biosensors|March 26, 2025
Regulatory Effects of RNA-Protein Interactions Revealed by Reporter Assays of Bacteria Grown on Solid MediaGuillermo Pérez-Ropero, Roswitha Dolcemascolo, Anna Pérez-Ràfols, et al.
Bioorganic & Medicinal Chemistry|November 5, 2002
Tetrapeptides as potent protease inhibitors of Hepatitis C Virus full-length NS3 (protease-helicase/NTPase)Anja Johansson, Anton Poliakov, Eva Akerblom, et al.
Protein Science : a Publication of the Protein Society|January 30, 2020
Establishing Trypanosoma cruzi farnesyl pyrophosphate synthase as a viable target for biosensor driven fragment-based lead discoveryGiulia Opassi, Helena Nordström, Arne Lundin, et al.
ACS Sensors|December 14, 2019
Estimating Detection Limits of Potentiometric DNA Sensors Using Surface Plasmon Resonance AnalysesXingxing Xu, Asta Makaraviciute, Eldar Abdurakhmanov, et al.
European Journal of Medicinal Chemistry|February 25, 2018
Pan-NS3 protease inhibitors of hepatitis C virus based on an R<sup>3</sup>-elongated pyrazinone scaffoldAnna Karin Belfrage, Eldar Abdurakhmanov, Eva Åkerblom, et al.
Nature Reviews. Drug Discovery|August 13, 2016
Biophysics in drug discovery: impact, challenges and opportunitiesJean-Paul Renaud, Chun-Wa Chung, U Helena Danielson, et al.
Bioorganic & Medicinal Chemistry|July 26, 2011
P2-P1' macrocyclization of P2 phenylglycine based HCV NS3 protease inhibitors using ring-closing metathesisAnna Lampa, Angelica E Ehrenberg, Aparna Vema, et al.
Pageof 13